ArticleNutrition, metabolism, and cardiovascular diseases : NMCD2022
Sodium nitrate supplementation improves blood pressure reactivity in patients with peripheral artery disease.
Article in Nutrition, metabolism, and cardiovascular diseases : NMCD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01983826 (Dietary Nitrates and Vascular Function in Patients With Peripheral Artery Disease), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Dietary Nitrates and Vascular Function in Patients With Peripheral Artery Disease
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
- Role of oral and gut microbiomes in enterosalivary nitrate metabolism and their effects on systemic disease.Frontiers in cellular and infection microbiology · 2025Review
- Investigating the association between nitrate dosing and nitrite generation by the human oral microbiota in continuous culture.Applied and environmental microbiology · 2024Article
- Antioxidant Capacity, Nitrite and Nitrate Content in Beetroot-Based Dietary Supplements.Foods (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
BACKGROUND &
aimsPeripheral artery disease (PAD) is characterized by elevated blood pressure (BP), low nitric oxide availability (NO), and exaggerated pressor responses to sympatho-excitatory stressors. Inorganic nitrate reduces peripheral BP in healthy and chronically diseased populations. The objective of this study was to investigate the effects of eight-weeks of sodium nitrate (NaNO
methods21 patients with PAD were recruited to participate in this study, undergoing 8-weeks of NaNO
conclusionOur data suggest that eight-weeks of NaNO CLINICAL TRIALS REGISTRATION NUMBER: NCT01983826.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.